Stay updated with breaking news from Dan Watterson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CSG® (NASDAQ: CSGS) today announced the first deployment of its joint solution with Axiata Digital Labs (ADL) at Namibia’s leading mobile operator.
Almost two years after abandoning its vaccine thanks to false positive HIV test results, the University of Queensland is entering human trials again on its homegrown savour from COVID.
University of Queensland scientists have developed a major vaccine breakthrough from the ashes of their initial COVID vaccine candidate.
"Devastated." That is the word Professor Paul Young from the University of Queensland uses to describe the canning of Australia's most promising COVID-19 vaccine. Although the vaccine's revolutionary molecular clamp technology returned a robust immune response to coronavirus in 216 trial recipients in the Phase 1 trial, volunteers were warned that fragments of a protein derived from the HIV virus could produce antibodies, or a partial immune response to HIV. Although there was no possibility the participants could acquire HIV, the vaccine had the potential to interfere with existing HIV te...
"Devastated." That is the word Professor Paul Young from the University of Queensland uses to describe the canning of Australia's most promising COVID-19 vaccine. Although the vaccine's revolutionary molecular clamp technology returned a robust immune response to coronavirus in 216 trial recipients in the Phase 1 trial, volunteers were warned that fragments of a protein derived from the HIV virus could produce antibodies, or a partial immune response to HIV. Although there was no possibility the participants could acquire HIV, the vaccine had the potential to interfere with existing HIV te...